Decrease of ERK/MAPK overactivation in prefrontal cortex reverses early memory deficit in a mouse model of Alzheimer's disease

Journal of Alzheimer's Disease : JAD
Mariana FeldMariano M Boccia

Abstract

Alzheimer's disease (AD) can be considered as a disease of memory in its initial clinical stages. Amyloid-β (Aβ) peptide accumulation is central to the disease initiation leading later to intracellular neurofibrillary tangles (NFTs) of cytoskeletal tau protein formation. It is under discussion whether different Aβ levels of aggregation, concentration, brain area, and/or time of exposure might be critical to the disease progression, as well as which intracellular pathways it activates. The aim of the present work was to study memory-related early molecular and behavioral alterations in a mouse model of AD, in which a subtle deregulation of the physiologic function of Aβ can be inferred. For this purpose we used triple-transgenic (3xTg) mice, which develop Aβ and tau pathology resembling the disease progression in humans. Memory impairment in novel object recognition task was evident by 5 months of age in 3xTg mice. Hippocampus and prefrontal cortex extra-nuclear protein extracts developed differential patterns of Aβ aggregation. ERK1/MAPK showed higher levels of cytosolic activity at 3 months and higher levels of nuclear activity at 6 months in the prefrontal cortex. No significant differences were found in JNK and NF-κB activit...Continue Reading

Citations

Jan 23, 2016·Frontiers in Pharmacology·Ramon YarzaMaria J Ramirez
Mar 3, 2015·Frontiers in Cellular Neuroscience·Hansen Wang
Apr 26, 2017·International Journal of Molecular Medicine·Jing Sun, Guangxian Nan
Feb 13, 2018·Experimental and Therapeutic Medicine·Xiaoqin HuChengyan Li
Feb 27, 2017·Inflammation Research : Official Journal of the European Histamine Research Society ... [et Al.]·Alessandra BittoDomenica Altavilla
Dec 17, 2019·Signal Transduction and Targeted Therapy·Yehong DuZhifang Dong
May 1, 2016·The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences·Maria LodeiroAngel Cedazo-Minguez
Jun 26, 2018·Journal of Molecular Neuroscience : MN·Roksana SoukhakLariMaryam Moosavi
Sep 28, 2018·Molecular Neurodegeneration·Michael DumbacherGerard Griffioen
Feb 2, 2020·Interdisciplinary Sciences, Computational Life Sciences·Fuzhang YangJiang Xie
Apr 4, 2017·Acta Biochimica Et Biophysica Sinica·Nannan JiaShaochun Chen
Dec 13, 2019·Evidence-based Complementary and Alternative Medicine : ECAM·Qiang ZengZhengzhi Wu
Sep 30, 2019·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Qiang ZengZhengzhi Wu
Dec 6, 2020·Signal Transduction and Targeted Therapy·Yehong DuZhifang Dong
Aug 7, 2021·Neurochemical Research·Dapinder KaurSimona Bungau
Dec 21, 2018·Brain Research·Amanda Brondani MucelliniGilberto Luiz Sanvitto

❮ Previous
Next ❯

Related Concepts

Related Feeds

Alzheimer's Disease: Tau & TDP-43

Alzheimer's disease is a neurodegenerative disease. This feed focuses on the underlying role of tau proteins and TAR DNA-binding protein 43, as well as other genetic factors, in Alzheimer's disease.

Alzheimer's Disease: APP

Amyloid precursor protein (APP) proteolysis is critical for the development of Alzheimer's disease, a neurodegenerative disease associated with accumulation of amyloid plaques in the brain. Here is the latest research on APP and Alzheimer's disease.

Alzheimer's Disease: Amyloid Beta

Alzheimer's disease is a neurodegenerative disease associated with the accumulation of amyloid plaques in the brain; these plaques are comprised of amyloid beta deposits. Here is the latest research in this field.

Related Papers

Progress in Molecular Biology and Translational Science
Steven P BraithwaiteAngus C Nairn
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
Manuela PolydoroPeter Davies
© 2021 Meta ULC. All rights reserved